CanSino Biologics Inc. (SHA:688185)
China flag China · Delayed Price · Currency is CNY
54.58
-0.26 (-0.47%)
Apr 25, 2025, 3:00 PM CST

CanSino Biologics Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Cash & Equivalents
-2,8223,4655,6454,447
Upgrade
Short-Term Investments
---275.2-
Upgrade
Trading Asset Securities
-1,3082,4821,862666.64
Upgrade
Cash & Short-Term Investments
3,2834,1305,9477,7835,114
Upgrade
Cash Growth
-20.50%-30.55%-23.59%52.19%577.49%
Upgrade
Accounts Receivable
-636.88855.49157.9322.14
Upgrade
Other Receivables
-3.980.5419.150.25
Upgrade
Receivables
-640.87856.03177.0822.4
Upgrade
Inventory
-352.85677.78875.62170.51
Upgrade
Prepaid Expenses
-0.25---
Upgrade
Other Current Assets
-57249.59454.49114.07
Upgrade
Total Current Assets
-5,1817,7309,2905,421
Upgrade
Property, Plant & Equipment
-3,0133,0692,218873.95
Upgrade
Long-Term Investments
-446.5650.1245.31265.44
Upgrade
Other Intangible Assets
-144.15220.92172.1236.9
Upgrade
Long-Term Deferred Tax Assets
-207.86196.41--
Upgrade
Long-Term Deferred Charges
-88.451.9526.1943.37
Upgrade
Other Long-Term Assets
-237.53150.37122.42107.78
Upgrade
Total Assets
-9,31911,46911,8746,748
Upgrade
Accounts Payable
-103.97253.12842.5760.57
Upgrade
Accrued Expenses
-453.14407.25362.44157.82
Upgrade
Short-Term Debt
-883.971,530990.68-
Upgrade
Current Portion of Long-Term Debt
-510.5945.7790.1140.16
Upgrade
Current Portion of Leases
-64.6348.7631.188.59
Upgrade
Current Income Taxes Payable
-0.54329.14-
Upgrade
Current Unearned Revenue
-3.571.48193.220.42
Upgrade
Other Current Liabilities
-544.9635.52322.08141.91
Upgrade
Total Current Liabilities
-2,5652,9252,861409.47
Upgrade
Long-Term Debt
-1,066878.014090
Upgrade
Long-Term Leases
-175.18198.29222.853.79
Upgrade
Long-Term Unearned Revenue
-216.72222.35201.48173.96
Upgrade
Long-Term Deferred Tax Liabilities
---0.56-
Upgrade
Other Long-Term Liabilities
-8.49---
Upgrade
Total Liabilities
-4,0314,2233,326677.22
Upgrade
Common Stock
-247.45247.45247.45247.45
Upgrade
Additional Paid-In Capital
-6,5746,6086,5986,588
Upgrade
Retained Earnings
--1,44042.711,150-764.69
Upgrade
Treasury Stock
--106.17-150.17--
Upgrade
Comprehensive Income & Other
--0.180.12--
Upgrade
Total Common Equity
5,0635,2756,7487,9956,071
Upgrade
Minority Interest
-12.81497.51552.84-
Upgrade
Shareholders' Equity
5,0635,2877,2468,5486,071
Upgrade
Total Liabilities & Equity
-9,31911,46911,8746,748
Upgrade
Total Debt
2,1022,7002,7011,375142.54
Upgrade
Net Cash (Debt)
1,1811,4303,2466,4084,971
Upgrade
Net Cash Growth
-17.41%-55.95%-49.34%28.90%745.44%
Upgrade
Net Cash Per Share
4.775.8013.1425.9121.56
Upgrade
Filing Date Shares Outstanding
249.18247.04246.77247.45247.45
Upgrade
Total Common Shares Outstanding
249.18247.04246.77247.45247.45
Upgrade
Working Capital
-2,6164,8056,4285,011
Upgrade
Book Value Per Share
20.5821.3527.3532.3124.53
Upgrade
Tangible Book Value
4,9445,1306,5277,8236,034
Upgrade
Tangible Book Value Per Share
20.1020.7726.4531.6124.38
Upgrade
Buildings
-978.89729.03724.6837.19
Upgrade
Machinery
-1,1891,050537.75120.73
Upgrade
Construction In Progress
-1,1141,342820.8760.05
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.